Oswego Health has added EYAL KORD, M.D. to its medical staff, where he will join 270-plus providers, representing multiple specialty services across the community at the new Upstate Urology at Oswego Health. Dr. Kord is a clinical assistant professor in the Department of Urology at SUNY Upstate Medical University. He has extensive experience in subspecialty […]
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
Oswego Health has added EYAL KORD, M.D. to its medical staff, where he will join 270-plus providers, representing multiple specialty services across the community at the new Upstate Urology at Oswego Health. Dr. Kord is a clinical assistant professor in the Department of Urology at SUNY Upstate Medical University. He has extensive experience in subspecialty urological oncology, as well as general urological care including enlarged prostates and stone disease. Dr. Kord is trained in minimally invasive techniques and is a daVinci certified robotic surgeon. With increasing demand for urological care, and the announced retirement of two local prestigious urologists, Upstate Urology and Oswego Health have partnered to provide access to the community. Originally from Israel, Kord earned his master’s degree in public health in from Tel Aviv University and his medical degree from Hadassah Ein Kerem in Jerusalem. Kord completed his post-graduate training as a fellow at the Society of Urologic Oncology at the Virginia Mason Medical Center in Seattle. He has published dozens of research and scholarly articles on prostate cancer as his passion is in investigating public health and the impact of urological diseases.